IGL-200 is a diagnostic test for detecting invasive fungal diseases (IFD), enabling rapid and accurate identification of fungal pathogens in clinical samples. Designed for laboratory use, it supports timely clinical decision-making in immunocompromised patients at high risk of IFD complications.
Manufactured by
Era Biology (Canada) Co., Ltd
Canada
Founded in 1997, Era Biology has been specializing in invasive fungal disease diagnostics for decades. Era Biology has evolved into a group company with 8 wholly owned subsidiaries, including 3 manufacturing entities: Genobio Pharmaceutical Co., Ltd., Beijing Gold Mountainriver Tech Development Co., Ltd., and Huabio Pharmaceutical Co., Ltd.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
Associates Of Cape Cod International Inc
United Kingdom · 4 relevant products
Pilot Gene Technology (Hangzhou) Co., Ltd.
China · 2 relevant products
bioactiva diagnostica GmbH
Germany · 5 relevant products
75 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →16 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
3 of 106 closest product alternatives
Associates Of Cape Cod International Inc · United Kingdom
The only FDA-cleared and CE-marked rapid test for invasive fungal infection (IFI) that detects (1→3)-β-D-glucan in serum. It is considered the gold standard in rapid screening for invasive fungal infections and provides reliable detection for hospital and reference laboratories.
Pilot Gene Technology (Hangzhou) Co., Ltd. · China
Digital PCR-based diagnostic kit for detection and identification of invasive fungal pathogens in blood and tissue samples. Provides rapid results for invasive fungal disease diagnosis.
Associates Of Cape Cod International Inc · United Kingdom
The only FDA-cleared and CE-marked rapid screening test for invasive fungal infection detection that identifies (1→3)-β-D-glucan in serum. Provides rapid diagnosis of life-threatening opportunistic infections in immunocompromised patients.
103 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products